All Stories

  1. Cancer Bioinformatics, New Chapter of Personalized Medicine
  2. Pulmonary nodules, knowledge renovation and comprehensive studies
  3. Personalized Oncology: Scientific and Technical Approaches
  4. Advances in Cancer Therapeutics and Genomics for Improved Patient Outcomes
  5. Magnetic water and clinical cancer chemotherapy
  6. Human suicide, clinical treatment overview
  7. Sexually transmitted disease diagnosis and treatments, risk factors from beyond
  8. Human suicide, risk factors and new perspective
  9. Suicide study, new approaches
  10. Human suicide, molecular framework
  11. Withdrawn: Professor Bin Xu, A Legendary Pharmacologist in People’s Republic of China
  12. Sialic Acids and Cancer: Pathophysiological Association between Metastatic Progress and Treatment
  13. Anticancer Drug Development, Pharmaceutical Progress
  14. Human Suicide, Biomedical Knowledge Advances
  15. Type 2 Diabetes Treatments in Countries of Different Economic Status
  16. Human suicide, biomedical knowledge and therapeutic advances
  17. Human Suicide, an Overview of Management Strategies
  18. COVID-19 Research, Public Health and Biomedical Basis
  19. Human Suicide, Management Landscape
  20. Anticancer Drug Development: Evaluative Architecture
  21. COVID-19 Study: A New Principle Discovery
  22. COVID-19 Study, Diagnostic and Therapeutic Transition
  23. Antimetastatic Drug, Pharmacologic Challenge and Opportunity
  24. Nursery services advances, global campaign
  25. Different approaches to bone transplantation surgery
  26. Bone Metastasis Diagnosis, Blood Biomarker Detections
  27. Anti-metastatic drug development, overview and perspectives
  28. Educational Perspectives for Nursery
  29. Is Tau Molecule Regarded as a Risk Factor for Human Suicide?
  30. Drug Sensitivity Testing for Cancer Therapy, Technique Analysis and Trends
  31. Suicide Curative Treatment Study and Drug Development
  32. Pulmonary nodules, is there any pathogenesis evidence?
  33. HIV/AIDS Curability Study, Different Approaches and Drug Combination
  34. Pulmonary nodules, surgery or other medication
  35. Bone Metastasis and Circulation Biomarkers Profiling Towards Personalized Cancer Medicine
  36. Pulmonary Nodules, Surgery or Other Medication
  37. Anti-Metastatic Drug Developments, Utility of More Animal Models
  38. Several approaches for anticancer drug development progress
  39. Drug Sensitivity Testing for Cancer Therapy, Key Areas
  40. COVID-19 infection for metabolic abnormal human beings
  41. Fundamental knowledge for nurses 
  42. Nursery promotion, education and system updating
  43. Cancer Bone Metastasis, Diagnostic Insights and Drug Selection
  44. Covid-19 Study, Pathology and Therapeutics
  45. Acupuncture for Bone Disease Treatments, Modern Approaches
  46. Cancer Bone Metastasis, Experimental Study
  47. Neuropsychiatric Approaches for Human Suicide Prediction and Management
  48. Osteoporosis Targeting, Possible Breakthroughs
  49. Neuropsychiatric insights for human suicide
  50. Bone Cancer and Metastasis Trials, Drug Treatment
  51. Neurobiology for human suicide
  52. Bone Disease Treatment Study, Major Pathways
  53. Pathology Study for Human Suicide
  54. Nursery activity and quality, chemistry between doctors and nurses
  55. Nursery education, narrow-range or wide-range
  56. Anticancer drug development, challenge and dilemma
  57. Life Origin on Earth, Knowledge Development
  58. HIV/AIDS treatment, therapeutic strategy break throughs
  59. Nursery education for diabetes
  60. Suicide Risks and Prevention, Neuropathogenic Study
  61. Medical Treatments for Chronic or Aggressive Diseases, Palliative Therapy and Nursery
  62. General information for nursery
  63. Historical analysis of suicide
  64. Drug sensitivity testing, a unique drug selection strategy
  65. Natural drug cancer treatments, strategies from herbal medicine to chemical or biological drugs
  66. Medical treatments for incurable diseases, palliative therapy
  67. Life Origin on Earth, Biochemical Approaches
  68. Nursery training, from technique details in schools into medical knowledge education in nursery career
  69. Herbal medicine in new era
  70. Nursery service, quality promotion
  71. Anti-Metastatic Drug Developments, Biomedical Mechanisms and Therapeutic Categorization
  72. Patient’s care and nursery in different diseases
  73. Ebola Therapeutic Study and Future Directions
  74. New HIV/AIDS Therapeutics
  75. Nursery Service in Modern Days
  76. Nursery Education, Capability and Service Promotion
  77. Nursery Science and Conventions
  78. Cancer Bioinformatics in Cancer Therapy
  79. Individualized Cancer Therapy
  80. Human Suicide Risk and Treatment Study
  81. Type 2 Diabetes Treatment and Drug Development Study
  82. Hypotheses for Life Origin on Earth, Comparison and Validation
  83. Type 2 Diabetes Study, Introduction and Perspective
  84. Type 2 Diabetes Mellitus Study, A Process of Enigma unraveling
  85. Anthocyanins and its biological & therapeutic characters
  86. Diabetes Prevention and Treatments, a Specific Topic for Modern Medicines
  87. A Critical Appraisal of Different Food Safety and Quality Management Tools to Accomplish Food Safety
  88. Pathology and treatments of obesity
  89. Obesity, Risks and Managements
  90. Keep up the pace of drug development evolution and expenditure
  91. An Overview of Obesity
  92. General Topics in the Field of Personalized Cancer Therapy
  93. Human Suicide Risk Study and Treatment: A Mathematical Approach
  94. Anti-Metastatic Drug Developments: Work Out towards New Direction
  95. Diabetes Mellitus and Male Aging: Pharmacotherapeutics and Clinical Implications
  96. Drug Combination in Clinical Cancer Treatments
  97. General outlook for individualized cancer therapy
  98. Ebola origin and treatment
  99. Different Disciplines in the Field of Suicide Study
  100. Cancer Bioinformatics for Updating Anticancer Drug Developments and Personalized Therapeutics
  101. HAART in HIV/AIDS Treatments
  102. Anticancer Drug Development, System Updating and Global Participations
  103. Life Origin on Earth, What is the Right Answer?
  104. Life Origin on Earth, What is the Right Answer?
  105. Anticancer Drug Development, Getting out from Bottleneck
  106. Anticancer Drug Development, Getting out from Bottleneck
  107. Human suicide study, major disciplines and treatment outcomes
  108. Anticancer drug development
  109. HIV in Human Genomes and Therapeutics
  110. HIV Biotherapy and Natural Chemotherapeutic Agents
  111. Anticancer Drug Combinations, How Far We can Go Through?
  112. Antimetastatic therapy at aberrant sialylation in cancer cells, a potential hotspot
  113. Life Origin on Earth, Insights among Different Arguments
  114. Genetics in Suicide Treatments, Modern Diagnosis Establishments
  115. Diabetes Preventions and Treatments, a Specific Topic for Modern Medicines
  116. Anticancer Drug Development, Breakthroughs are Waiting
  117. Cancer metastasis treatment, a key drawbacks
  118. The suicide treatment, a new model
  119. HIV Vaccine for Prevention and Cure, A Mission Possible
  120. Zika Therapy
  121. HIV vaccine
  122. Discover Natural Chemical Drugs in Modern Medicines
  123. Mathematics in biomedical science
  124. The origin of HIV
  125. Human suicide study
  126. Mathematics or Physics-Majored Students on the Biomedical Fields, Insiders or Outsiders?
  127. Pharmacogenetics of Cancer Therapy
  128. Anticancer Drug Sensitivity Testing
  129. New Perspectives of HIV/AIDS Therapy Study
  130. Antidepressant treatment study
  131. Clinical neoplasm metastasis treatments according to patient's personal conditions.
  132. Assistant cancer treatments in the clinic
  133. Drug sensitivity testing in clinical cancer treatments
  134. Anticancer drug combination in the clinic
  135. Anticancer drug pharmacogenomics in cancer chemotherapy
  136. Cost-effectiveness for personalized cancer therapy
  137. Conclusion
  138. Introduction
  139. Discussion
  140. Cancer biomarker/bioinformatics detection in clinical cancer treatments
  141. Anti-diabetic treatments
  142. Anticancer Drug Combinational Study
  143. The Origins of HIV
  144. Plasma Fibrinogen Concentrations in Patients with Solid Tumors and Therapeutic Improvements by Combining Anticoagulants or Fibrinolytical Agents
  145. Anticancer Drug Combinations, A Big Momentum is Needed
  146. Anticancer Drug Development, a Matter of Money or a Matter of Idea?
  147. Future Perspectives for Controlling Ebola Epidemics
  148. Ebola Origin and Therapies
  149. Cancer Bioinformatics, its Impacts on Cancer Therapy
  150. Copyright
  151. List of figures and tables
  152. Anti-diabetic treatments, patho-therapeutic relation
  153. Origin of Ebola, hypothesis
  154. Personalized Cancer Therapy: A Perspective
  155. Rethink Of Diabetes Treatment and Drug Development
  156. Pharmacogenomics in human suicide prediction and treatments
  157. Cancer metastasis treatment study and drug developments
  158. Challenge for HIV/AIDS therapy
  159. Cost-effectiveness Considerations of Individualized Cancer Chemotherapy
  160. Drug Combinations in Cancer Treatments
  161. New Insights into Individualized Antimetastatic Therapy
  162. Anticancer drugs on serum sialic acid level in mice bearing LLC
  163. Drug Combinations in Cancer Treatments
  164. Genetics in Neural Toxicity of Drugs
  165. Avian flu, pathogenesis and therapeutic study
  166. First Genetic Information Replication in Life Origin on Earth
  167. Origins of Life, A New Cooperative Model
  168. Cancer Metastases and Clinical Therapies
  169. Origins of Life, RNA world or alternative RNA world
  170. Development of Antimetastatic Drugs by Targeting Tumor Sialic Acids
  171. Individualized Cancer Chemotherapy by Detecting Cancer Biomarkers
  172. Antimetastatic Therapies according to Metastatic Cascade
  173. Genetics in antidepressant-induced suicide
  174. Pathology of Drug-induced mania & suicide
  175. Influenza treatment
  176. High Active Anti-retroviral Therapy for HIV/AIDS, Progresses and Drawback
  177. Individualized cancer chemotherapy
  178. High Active Antiretroviral Therapy for HIV/AIDS-Early Intervention or Later Intervention?
  179. The Hypotheses for the Pathogeny of Drug-Induced Mania and Suicide
  180. The Relationship between Tumor Sialic Acids and Neoplasm Metastasis and as a Drug Target
  181. Genomic study of antidepressant-induced suicide
  182. Aberrant sialylation in tumor cells
  183. Anti-mobility of Bisdioxopiperanes against human mammary tumors
  184. Antimetastatic activity and mechanisms of action of Bisdioxopiperazine compounds
  185. Neural toxicity of drugs
  186. Anticancer activity and mechanisms of Bisdioxopiperazines
  187. Different Spontaneous Pulmonary Metastasis Inhibitions against Lewis Lung Carcinoma in Mice by Bisdioxopiperazine Compounds of Different Treatment Schedules
  188. 14C-probimane in the mice bearing LLC
  189. Unsatisfactory design of human AIDS genome research
  190. Antidepressant in Cancer Treatment
  191. AIDS and human genome studies, from a hypothesis to systematic approaches
  192. Antidepressants in Human suicide
  193. Mathematical model in therapeutic risk prediction
  194. Fibrinogen in neoplasm metastasis
  195. Sequencing the whole genome of infected human cells obtained from diseased patients – a proposed strategy for understanding and overcoming AIDS or other deadest virus-infected diseases
  196. Relationship Between Blood Fibrinogen Concentration and Pathological Features of Cancer Patients: A 139-case Clinical Study
  197. Medicinal Chemistry of Probimane and MST-16: Comparison of Anticancer Effects Between Bisdioxopiperazines
  198. Individualized cancer chemotheray
  199. Anti-proliferative and chromosome segregation by probimane and MST-16
  200. Effect of Anti-Cancer Drugs on the Binding of 125I-Fibrinogen to Two Leukaemia Cell Lines In Vitro
  201. Antitumor effects of two bisdioxopiperazines against two experimental lung cancer models in vivo
  202. Inhibition of probimane on lipid peroxidation of rabbit and human erythrocytes
  203. Aberration of sialylation in neoplasm metastasis and possible therapeutics
  204. Effects of Cancer Chemotherapy on the Blood Fibrinogen Concentrations of Cancer Patients
  205. Effect of magnetized water on the mice given high doses of antineoplastic drugs
  206. Inhibition of probimane on lipoperoxidation of human red cells in vitro
  207. Enzyme dynamic study on calmodulin Ca++-Mg++-ATPase system of red blood cells inhibited by α-anordrin and probimane
  208. Journal of Clinical and Medical Reviews